Publications by authors named "Charlotte Jorias"
Article Synopsis
- The study examined the effects of external beam radiation therapy (EBRT) on oligometastatic hormone-sensitive prostate cancer (mHSPC) patients, focusing on their progression to metastatic castration-resistant prostate cancer (mCRPC) and overall mortality (OM).
- The research included 37 patients from a database, showing a median follow-up of 13 months and that most had a good performance status (ECOG 0) and responded well to treatments.
- Findings indicated that 84% underwent androgen deprivation therapy alongside EBRT, with a median time to developing mCRPC being 50 months and overall mortality rate of 15% after 24 months of treatment, suggesting that MDT is effective and safe for this patient population.
